FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004776555> ?p ?o ?g. }

• W3004776555 abstract "This study aimed to assess the declared benefits of the new test using antibodies against tissue transglutaminase in complex with gliadin representing a neo-epitope in the IgA and IgG class of immunoglobulins compared with currently used tissue transglutaminase antibodies in the IgA class of immunoglobulins among children.In the cross-sectional study (P1 study, n = 406) and two small-size prospective observational studies (P2 study, n = 59 and P3 study, n = 12), serum samples from all children were simultaneously tested for endomysial antibodies, IgA tissue transglutaminase antibodies, and antibodies against tissue transglutaminase in complex with gliadin in the IgA and IgG class of immunoglobulins. The exact McNemar test, Wilcoxon test, and Spearman's correlation coefficient were used to analyze the data.We found a significant asymmetry of the tissue transglutaminase antibodies test compared with the antibodies against tissue transglutaminase neo-epitope test (P1). More patients (1.5%) had tissue transglutaminase an¬tibodies positive and antibodies against tissue transglutaminase neo-epitope negative results, whereas no patients had tissue transglutaminase antibodies negative and antibodies against tissue transglutaminase neo-epitope positive results. Of 59 children with tissue transglutaminase antibodies and/or endomysial antibodies positive results (P2), one (1.7%) did not have celiac disease. In agreement with the P1 study, four patients (6.8%) with confirmed celiac disease were tissue transglutaminase antibodies positive and antibodies against tissue transglutaminase neo-epitope negative. In this group, the sensitivity of the antibodies against tissue transglutaminase neo-epitope test for diagnosis of celiac disease was 91.4% (95% confidence interval, 81.0 - 97.1%). Among children diagnosed with functional gastrointestinal disorder (P3), all had negative serological test results, and none was diagnosed with celiac disease.The results do not indicate that antibodies against tissue transglutaminase neo-epitope test would be an unambiguously better test than the currently used tissue transglutaminase antibodies." @default.
• W3004776555 created "2020-02-14" @default.
• W3004776555 creator A5004532179 @default.
• W3004776555 creator A5007747131 @default.
• W3004776555 creator A5014658115 @default.
• W3004776555 creator A5039257190 @default.
• W3004776555 creator A5049870140 @default.
• W3004776555 creator A5077256693 @default.
• W3004776555 date "2020-01-01" @default.
• W3004776555 modified "2023-10-06" @default.
• W3004776555 title "Reliability of Autoantibodies Against a Tissue Transglutaminase Neo-Epitope for the Diagnosis of Pediatric Celiac Disease" @default.
• W3004776555 doi "https://doi.org/10.7754/clin.lab.2019.190530" @default.
• W3004776555 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32013344" @default.
• W3004776555 hasPublicationYear "2020" @default.
• W3004776555 type Work @default.
• W3004776555 sameAs 3004776555 @default.
• W3004776555 citedByCount "0" @default.
• W3004776555 crossrefType "journal-article" @default.
• W3004776555 hasAuthorship W3004776555A5004532179 @default.
• W3004776555 hasAuthorship W3004776555A5007747131 @default.
• W3004776555 hasAuthorship W3004776555A5014658115 @default.
• W3004776555 hasAuthorship W3004776555A5039257190 @default.
• W3004776555 hasAuthorship W3004776555A5049870140 @default.
• W3004776555 hasAuthorship W3004776555A5077256693 @default.
• W3004776555 hasConcept C142724271 @default.
• W3004776555 hasConcept C159654299 @default.
• W3004776555 hasConcept C163764329 @default.
• W3004776555 hasConcept C178498320 @default.
• W3004776555 hasConcept C181199279 @default.
• W3004776555 hasConcept C195616568 @default.
• W3004776555 hasConcept C203014093 @default.
• W3004776555 hasConcept C55493867 @default.
• W3004776555 hasConcept C71924100 @default.
• W3004776555 hasConcept C86803240 @default.
• W3004776555 hasConceptScore W3004776555C142724271 @default.
• W3004776555 hasConceptScore W3004776555C159654299 @default.
• W3004776555 hasConceptScore W3004776555C163764329 @default.
• W3004776555 hasConceptScore W3004776555C178498320 @default.
• W3004776555 hasConceptScore W3004776555C181199279 @default.
• W3004776555 hasConceptScore W3004776555C195616568 @default.
• W3004776555 hasConceptScore W3004776555C203014093 @default.
• W3004776555 hasConceptScore W3004776555C55493867 @default.
• W3004776555 hasConceptScore W3004776555C71924100 @default.
• W3004776555 hasConceptScore W3004776555C86803240 @default.
• W3004776555 hasIssue "01+02/2020" @default.
• W3004776555 hasLocation W30047765551 @default.
• W3004776555 hasLocation W30047765552 @default.
• W3004776555 hasOpenAccess W3004776555 @default.
• W3004776555 hasPrimaryLocation W30047765551 @default.
• W3004776555 hasRelatedWork W1667117237 @default.
• W3004776555 hasRelatedWork W1796990215 @default.
• W3004776555 hasRelatedWork W2024986242 @default.
• W3004776555 hasRelatedWork W2079434831 @default.
• W3004776555 hasRelatedWork W2101875571 @default.
• W3004776555 hasRelatedWork W2155275047 @default.
• W3004776555 hasRelatedWork W2161246929 @default.
• W3004776555 hasRelatedWork W2312643923 @default.
• W3004776555 hasRelatedWork W2494708045 @default.
• W3004776555 hasRelatedWork W4241977884 @default.
• W3004776555 hasVolume "66" @default.
• W3004776555 isParatext "false" @default.
• W3004776555 isRetracted "false" @default.
• W3004776555 magId "3004776555" @default.
• W3004776555 workType "article" @default.